Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiation for vulvar cancer with sentinel node metastasis (GROINSS-VIII)
NCT05076942Phase 2Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2021
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cisplatin in vulvar cancer, sponsored by University Medical Center Groningen. Started Jan 2021; status: recruiting.
02
Drugs
cisplatin
03
Conditions
vulvar cancer
Beyond the preview
Go deeper on NCT05076942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076942.